Statera Biopharma, Inc.
STABDelisted Mar 3, 2023- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001318641
Statera Biopharma, Inc. was delisted on Mar 3, 2023; its insiders filed their last Form 4 on Oct 28, 2021; 29 institutions reported holding it in 13F filings for Q4 2022, worth $197.5K in total; no superinvestor held it.
Q2 2022 vs. Q1 2022
How the institutions holding Statera Biopharma, Inc. changed between Q1 2022 and Q2 2022.
All holders in Q2 2022All holders in Q1 2022
| Measure | Q1 2022 | Q2 2022 | Change |
|---|---|---|---|
| Holders | 33 | 35 | +2 |
| Shares | 2.13M | 3.16M | +1.02M (+48.0%) |
| Value | $669.2K | $894.9K | +$225.7K (+33.7%) |
New holders (8)
Institutions that held Statera Biopharma, Inc. at the end of Q2 2022 but not at the end of Q1 2022.
| Institution | Shares | Value | % of portfolio |
|---|---|---|---|
| Susquehanna International Group, LLP | 151,848 | $43.0K | 0.00% |
| Tower Research Capital LLC (TRC) | 23,821 | $7.00K | 0.00% |
| Millennium Management LLC | 18,695 | $5.00K | 0.00% |
| Beacon Pointe Advisors, LLC | 18,494 | $5.00K | 0.00% |
| United Capital Management of KS, Inc. | 15,000 | $4.00K | 0.00% |
| Harbour Investments, Inc. | 1,381 | $0 | 0.00% |
| Simplex Trading, LLC | 200 | $0 | 0.00% |
| Advisor Group Holdings, Inc. | 565 | $0 | 0.00% |
Sold out (6)
Institutions that held Statera Biopharma, Inc. at the end of Q1 2022 and filed for Q2 2022 without it.
| Institution | Shares, Q1 2022 | Value, Q1 2022 |
|---|---|---|
| Empery Asset Management, LP | 333,016 | $105.0K |
| Virtu Financial LLC | 157,678 | $50.0K |
| Sabby Management, LLC | 69,103 | $22.0K |
| Citadel Advisors LLC | 20,368 | $7.00K |
| HRT Financial LP | 22,539 | $7.00K |
| Orion Capital Management LLC | 50 | $0 |